238 related articles for article (PubMed ID: 37499587)
1. Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
Swinford CG; Risacher SL; Vosmeier A; Deardorff R; Chumin EJ; Dzemidzic M; Wu YC; Gao S; McDonald BC; Yoder KK; Unverzagt FW; Wang S; Farlow MR; Brosch JR; Clark DG; Apostolova LG; Sims J; Wang DJ; Saykin AJ
Neurobiol Aging; 2023 Oct; 130():103-113. PubMed ID: 37499587
[TBL] [Abstract][Full Text] [Related]
2. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
Albrecht D; Isenberg AL; Stradford J; Monreal T; Sagare A; Pachicano M; Sweeney M; Toga A; Zlokovic B; Chui H; Joe E; Schneider L; Conti P; Jann K; Pa J
J Neurosci; 2020 Oct; 40(44):8573-8586. PubMed ID: 33046556
[TBL] [Abstract][Full Text] [Related]
3. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
4. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
5. Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer's disease.
Lee H; Fu JF; Gaudet K; Bryant AG; Price JC; Bennett RE; Johnson KA; Hyman BT; Hedden T; Salat DH; Yen YF; Huang SY
J Cereb Blood Flow Metab; 2024 May; 44(5):787-800. PubMed ID: 38000018
[TBL] [Abstract][Full Text] [Related]
6. Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Disease Continuum.
Li J; Zeng Q; Luo X; Li K; Liu X; Hong L; Zhang X; Zhong S; Qiu T; Liu Z; Chen Y; Huang P; Zhang M;
J Alzheimers Dis; 2023; 95(1):287-298. PubMed ID: 37483006
[TBL] [Abstract][Full Text] [Related]
7. Regional Hypoperfusion Predicts Decline in Everyday Functioning at Three-Year Follow-Up in Older Adults without Dementia.
Sanchez DL; Thomas KR; Edmonds EC; Bondi MW; Bangen KJ;
J Alzheimers Dis; 2020; 77(3):1291-1304. PubMed ID: 32831202
[TBL] [Abstract][Full Text] [Related]
8. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
[TBL] [Abstract][Full Text] [Related]
9. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.
Rodriguez-Vieitez E; Montal V; Sepulcre J; Lois C; Hanseeuw B; Vilaplana E; Schultz AP; Properzi MJ; Scott MR; Amariglio R; Papp KV; Marshall GA; Fortea J; Johnson KA; Sperling RA; Vannini P
Mol Psychiatry; 2021 Dec; 26(12):7813-7822. PubMed ID: 34588623
[TBL] [Abstract][Full Text] [Related]
10. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
[TBL] [Abstract][Full Text] [Related]
11. Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer's continuum.
Rubinski A; Tosun D; Franzmeier N; Neitzel J; Frontzkowski L; Weiner M; Ewers M
Neurobiol Aging; 2021 Jun; 102():111-118. PubMed ID: 33765424
[TBL] [Abstract][Full Text] [Related]
12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
13. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.
Wierenga CE; Hays CC; Zlatar ZZ
J Alzheimers Dis; 2014; 42 Suppl 4(Suppl 4):S411-9. PubMed ID: 25159672
[TBL] [Abstract][Full Text] [Related]
14. Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population.
Padrela BE; Lorenzini L; Collij LE; García DV; Coomans E; Ingala S; Tomassen J; Deckers Q; Shekari M; Geus EJ; van de Giessen E; Kate MT; Visser PJ; Barkhof F; Petr J; Braber AD; Mutsaerts HJ
J Cereb Blood Flow Metab; 2023 Oct; 43(10):1726-1736. PubMed ID: 37231665
[TBL] [Abstract][Full Text] [Related]
15. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
[TBL] [Abstract][Full Text] [Related]
16. Arterial spin labeling versus
Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD.
Bryant AG; Manhard MK; Salat DH; Rosen BR; Hyman BT; Johnson KA; Huang S; Bennett RE; Yen YF
Curr Alzheimer Res; 2021; 18(9):711-720. PubMed ID: 34825871
[TBL] [Abstract][Full Text] [Related]
18. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
[TBL] [Abstract][Full Text] [Related]
19. Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study.
Visser D; Verfaillie SCJ; Bosch I; Brouwer I; Tuncel H; Coomans EM; Rikken RM; Mastenbroek SE; Golla SSV; Barkhof F; van de Giessen E; van Berckel BNM; van der Flier WM; Ossenkoppele R
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2409-2419. PubMed ID: 36976303
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
